Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival-Reference-Cited by-同舟云学术

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

Published:2021-01-21 Issue:1 Volume:4 Page:e2021869
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Dudani Shaan¹,de Velasco Guillermo²,Wells J. Connor¹,Gan Chun Loo¹,Donskov Frede³,Porta Camillo⁴⁵,Fraccon Anna⁶,Pasini Felice⁷,Lee Jae Lyun⁸,Hansen Aaron⁹,Bjarnason Georg A.¹⁰,Beuselinck Benoit¹¹,Pal Sumanta K.¹²,Yuasa Takeshi¹³,Kroeger Nils¹⁴,Kanesvaran Ravindran¹⁵,Reaume M. Neil¹⁶,Canil Christina¹⁶,Choueiri Toni K.¹⁷,Heng Daniel Y. C.¹

Affiliation:

1. Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada

2. Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain

3. Department of Oncology,Aarhus University Hospital, Aarhus, Denmark

4. Department of Internal Medicine, University of Pavia, Pavia, Italy

5. Now with Department of Oncology, University of Bari Aldo Moro, Bari, Italy

6. CDC Pererzoli, Peschiera del Garda, Italy

7. Oncologia Medica Ospedale Santa Maria della Misericordia, Rovigo, Italy

8. Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

9. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

10. Division of Medical Oncology, Sunnybrook Research Institute, Toronto, Ontario, Canada

11. Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium

12. City of Hope Comprehensive Cancer Center, Duarte, California

13. Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

14. Department of Urology, University Medicine Greifswald, Greifswald, Germany

15. Department of Medical Oncology, National Cancer Centre Singapore, Singapore

16. The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, Ontario, Canada

17. Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2775361/dudani_2021_oi_200737_1610558724.4577.pdf

Reference32 articles.

1. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia.;Srigley;Am J Surg Pathol,2013

2. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.;Patard;J Clin Oncol,2005

3. Systemic therapy for metastatic renal-cell carcinoma.;Choueiri;N Engl J Med,2017

4. Comprehensive molecular characterization of clear cell renal cell carcinoma.;Cancer Genome Atlas Research Network;Nature,2013

5. Comprehensive molecular characterization of papillary renal-cell carcinoma.;Linehan;N Engl J Med,2016

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-12

2. Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion;Cancer Letters;2024-10

3. Cost-effectiveness of atezolizumab plus bevacizumab as first-line therapy for metastatic renal cell carcinoma;Expert Review of Pharmacoeconomics & Outcomes Research;2024-09

4. Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal Disease;Urology Practice;2024-09

5. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma;Modern Pathology;2024-09